Transcat, Inc. (NASDAQ:TRNS) Director Alan H. Resnick sold 1,916 shares of the business’s stock in a transaction that occurred on Friday, June 8th. The stock was sold at an average price of $19.79, for a total transaction of $37,917.64. Following the completion of the transaction, the director now owns 35,400 shares in the company, valued at approximately $700,566. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of NASDAQ TRNS traded up $0.25 during midday trading on Thursday, reaching $19.45. The stock had a trading volume of 100 shares, compared to its average volume of 14,986. The company has a market capitalization of $145.03 million, a P/E ratio of 27.25, a price-to-earnings-growth ratio of 2.71 and a beta of 0.42. Transcat, Inc. has a twelve month low of $11.80 and a twelve month high of $21.10. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.38 and a current ratio of 1.98.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Wednesday, May 23rd. The scientific and technical instruments company reported $0.27 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.04. The firm had revenue of $42.45 million for the quarter, compared to the consensus estimate of $40.70 million. Transcat had a net margin of 3.82% and a return on equity of 11.10%. analysts forecast that Transcat, Inc. will post 0.93 earnings per share for the current year.

Several hedge funds and other institutional investors have recently modified their holdings of TRNS. Renaissance Technologies LLC lifted its position in shares of Transcat by 118.8% in the 4th quarter. Renaissance Technologies LLC now owns 53,394 shares of the scientific and technical instruments company’s stock worth $761,000 after purchasing an additional 28,994 shares during the period. Deutsche Bank AG lifted its position in shares of Transcat by 86.8% during the 4th quarter. Deutsche Bank AG now owns 33,695 shares of the scientific and technical instruments company’s stock valued at $480,000 after acquiring an additional 15,653 shares during the period. Quantum Capital Management lifted its position in shares of Transcat by 31.6% during the 1st quarter. Quantum Capital Management now owns 83,824 shares of the scientific and technical instruments company’s stock valued at $1,312,000 after acquiring an additional 20,110 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Transcat by 2.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 316,063 shares of the scientific and technical instruments company’s stock valued at $4,946,000 after acquiring an additional 8,621 shares during the period. Finally, UBS Group AG lifted its position in shares of Transcat by 62.9% during the 1st quarter. UBS Group AG now owns 66,465 shares of the scientific and technical instruments company’s stock valued at $1,040,000 after acquiring an additional 25,664 shares during the period. Hedge funds and other institutional investors own 53.64% of the company’s stock.

A number of research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Transcat from a “buy” rating to a “hold” rating in a research report on Thursday. ValuEngine upgraded shares of Transcat from a “hold” rating to a “buy” rating in a research report on Wednesday, April 11th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Transcat presently has a consensus rating of “Buy” and an average target price of $20.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services.

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.